QuidelOrtho (QDEL) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Apr, 2026Executive summary
The annual meeting will be held virtually on June 16, 2026, with voting on director elections, executive compensation, and auditor ratification.
Shareholders can vote online, by phone, or by mail, and may change their vote up to the meeting date.
The Board recommends voting for all director nominees, for the say-on-pay proposal, and for the external auditor proposal.
Proxy materials are available online, and the company uses a notice-and-access method to reduce paper use.
Voting matters and shareholder proposals
Shareholders will vote on electing 10 directors for one-year terms, approving executive compensation on an advisory basis, and ratifying KPMG as the independent auditor.
Shareholders may submit proposals or director nominations for future meetings, following specific bylaw procedures.
Board of directors and corporate governance
The Board consists of 10 members, with all but the CEO considered independent.
Board leadership is separated between an independent Chair and the CEO.
Committees include Audit, Compensation, Nominating and Governance, and Science and Technology, all composed of independent directors.
Directors are elected annually, and the Board conducts regular evaluations and executive sessions.
Board diversity includes gender and ethnic representation, and directors are subject to stock ownership guidelines.
Latest events from QuidelOrtho
- Key votes include director elections, executive pay, and auditor ratification at the 2026 meeting.QDEL
Proxy filing27 Apr 2026 - FY26 revenue guidance of $2.9B and margin expansion driven by innovation and recurring revenue.QDEL
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - 2025 saw margin expansion and strong Labs growth, with FY26 guidance projecting higher cash flow.QDEL
Q4 202512 Feb 2026 - Q2 revenue fell, but recurring revenue rose 5% as cost savings and impairments shaped results.QDEL
Q2 20242 Feb 2026 - Q1 2024 saw 6% revenue growth ex-COVID-19, with margin focus and global expansion initiatives.QDEL
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Savanna platform and cost optimization drive growth, with Investor Day set for 1H 2025.QDEL
Morgan Stanley’s 22nd Annual Global Healthcare Conference22 Jan 2026 - Savanna platform launch and cost actions position the business for improved growth and profitability.QDEL
Baird 2024 Global Healthcare Conference21 Jan 2026 - Q3 revenue fell 2% but margin rose; $1.7B impairment led to $1.87B net loss YTD.QDEL
Q3 202415 Jan 2026 - 2025 margin expansion, cost savings, and SAVANNA scale-up drive a two- to three-year growth plan.QDEL
Citi's 2024 Global Healthcare Conference11 Jan 2026